文献速递神经肿瘤

上皮膜蛋白2(EMP2)作为脑膜瘤分子标志物及其与血管生成相关性的鉴定

Identification of epithelial membrane protein 2 (EMP2) as a molecular marker and correlate for angiogenesis in meningioma.
PubMed 文献 · J Neurooncol · 2020-01-24

研究检测16例脑膜瘤手术标本与3例尸检正常脑组织中EMP2的表达,发现脑膜瘤EMP2 mRNA和蛋白表达均显著高于正常脑膜和脑组织,且EMP2表达与血管瘤型模式、VEGF-A mRNA及术中出血量正相关。

要点

  • 脑膜瘤EMP2 mRNA表达高于正常脑膜(P=0.0013)和正常脑组织(P=0.0011)。
  • 16例脑膜瘤标本均显示强EMP2蛋白表达,3例正常脑组织无表达(P<0.001)。
  • EMP2表达与血管瘤型组织学模式(P=0.0597)、VEGF-A mRNA(P<0.001)及术中出血量(P=0.037)正相关。

核心结论

  • EMP2在正常脑组织中不表达,但在脑膜瘤中mRNA和蛋白表达持续高表达,可能作为脑膜瘤有用的分子标志物。

研究设计与样本

  • 收集3例常规尸检的非病理脑组织和16例因脑膜瘤需手术切除的肿瘤标本。
  • 采用免疫组化和蛋白质印迹分析评估EMP2蛋白表达,并利用手术标本检测EMP2 mRNA表达,通过分析多个独立NCBI GEO数据库进行验证。

主要发现

  • 脑膜瘤EMP2 mRNA表达水平高于非病理脑膜(P=0.0013)和脑组织(P=0.0011)。
  • 全部16例脑膜瘤标本均显示强EMP2蛋白表达,而3例正常脑组织样本未见可观察的蛋白表达(P<0.001)。
  • 5例样本经蛋白质印迹分析确认EMP2表达,EMP2蛋白强度与组织学染色评分正相关(R2=0.780;P=0.047)。
  • 未发现EMP2 mRNA或蛋白水平与WHO分级或增殖标志物之间的关联。
  • EMP2表达与组织学评估的血管瘤型模式正相关(P=0.0597),与VEGF-A mRNA表达正相关(P<0.001),与术中出血量等肿瘤血管生成的临床标志物正相关(P=0.037)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Although intracranial meningiomas are the most common primary brain tumor in adults, treatment options are few and have traditionally been limited to surgical resection and radiotherapy. Additional targeted therapies and biomarkers are needed, especially as complete surgical resection is frequently not feasible in many patients. METHODS: Non-pathologic brain tissue from 3 patients undergoing routine autopsies and tumor specimens from 16 patients requiring surgical resection for meningioma were collected. EMP2 protein expression was evaluated by immunohistochemistry and western blot analysis. EMP2 mRNA expression was also investigated using surgical specimens and validated by analysis of several independent NCBI GEO databases. RESULTS: EMP2 mRNA expression levels were found to be higher in meningioma relative to non-pathologic meninges (P = 0.0013) and brain (P = 0.0011). Concordantly, strong EMP2 protein expression was demonstrated in 100% of meningioma specimens from all 16 patients, with no observable protein expression in normal brain tissue samples from 3 subjects (P < 0.001). EMP2 expression was confirmed by western blot analysis in five samples, with EMP2 protein intensity positively correlating with histologic staining score (R2 = 0.780; P = 0.047). No association was found between EMP2 mRNA or protein levels and WHO grade or markers of proliferation. However, EMP2 expression was positively associated with an angiomatous pattern on histologic evaluation (P = 0.0597), VEGF-A mRNA expression (P < 0.001), and clinical markers of tumor vascularity such as operative blood loss (P = 0.037). CONCLUSIONS: EMP2 is not found in normal brain tissue, yet has shown consistently high mRNA and protein expression in meningiomas, and may serve as a useful molecular marker for these tumors.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Patel KS, Kejriwal S, Sun MM, et al. Identification of epithelial membrane protein 2 (EMP2) as a molecular marker and correlate for angiogenesis in meningioma. J Neurooncol. 2020. PMID: 31981014. doi:10.1007/s11060-020-03401-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。